| 标题 |
 Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：Lancet 作者：Lenz G, Trněný M, Burke JM, Nowakowski GS, Fox CP, Chiappella A, Duell J, Jeon YW, Cheah CY, Westin J, Ye JZ, Caguioa PB, Belada D, Shin HJ, Oh SY, Amorim S, Ku M, Mocikova H, Jiménez JL, Gaidano G, Rosenwald A, Chiarle R, Colucci P, Ioannidis S, Cheng L, Vitolo U, frontMIND Study Investigators 出版日期：2026-05-30 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Nole
cdercder
东方元语
张欢馨
呵呵
OK
aajhajkahna
MozzieMiao
昏睡的蟠桃
xing_xing
Kao
可爱的小paper
丰富语蕊
cat
v0id
认真芷容
yjh123
Nexus
七听
初景
皖公网安备34019202002308
